bourva
SGBV · ALG Health Care BIO

Biopharm share price

BIO · Biopharm
DZD 1,250.00 ▼ DZD 6.38 · -0.51%
Market closed · 10:15 local Jun 26, 2026 Prices delayed ≥15 min Sample data

Price chart

Key statistics

Market cap
DZD 47.50B
P/E (TTM)
12.0×
EPS (TTM)
DZD 104.17
Dividend yield
3.17%
52-week range
DZD 861.14 – DZD 1,343.07
Avg volume
105.3K
Beta
1.14
Prev close
DZD 1,256.38

About Biopharm

AI-assisted summary

Biopharm (BIO) is a company listed on SGBV in the Health Care sector. This page summarises its share price, key statistics, dividends and fundamentals using delayed and sample data — figures may differ from official sources.

Dividend history

Annual payout (TTM): DZD 39.63 · Forward yield: 3.17%
Ex-date Pay date Amount Frequency Dividend yield
Jun 21, 2026 Jun 28, 2026 DZD 39.63 Annual 3.17%
Jun 21, 2025 Jun 28, 2025 DZD 37.86 Annual 3.03%
Jun 21, 2024 Jun 28, 2024 DZD 36.99 Annual 2.96%

Financials

Annual figures, last 5 fiscal years.

Date Revenue Net income EPS (TTM) P/E (TTM)
FY2024 DZD 34.32B DZD 6.16B DZD 76.27 13.5×
FY2023 DZD 30.64B DZD 2.74B DZD 83.13 13.1×
FY2022 DZD 25.89B DZD 2.30B DZD 93.26 12.4×
FY2021 DZD 22.21B DZD 2.28B DZD 103.01 11.9×
FY2020 DZD 18.84B DZD 2.42B DZD 107.35 10.3×

Stock splits

No stock splits on record for Biopharm.

Analyst forecast

12-month price target
DZD 1,165.20
Consensus rating
Sell
Implied upside
-6.78%
Based on 25 analysts
12-month

Aggregated analyst estimates (sample)

Related

Frequently asked questions

What is the current Biopharm share price?

Biopharm (BIO) last traded at DZD 1,250.00, as of Jun 26, 2026. Prices on bourva are delayed and shown for reference only.

Does Biopharm pay a dividend?

Yes — Biopharm has a forward dividend yield of about 3.17%, based on its trailing 12-month payout.

What is Biopharm's market capitalisation?

Biopharm has an approximate market capitalisation of DZD 47.50B.

What is Biopharm's P/E ratio?

Biopharm trades at a trailing P/E ratio of about 12.0.

Compare with another ticker
See two tickers side by side — price, valuation and dividends.